scholarly journals Incidence of Treatment for End-Stage Renal Disease Among Individuals With Diabetes in the U.S. Continues to Decline: Response to Burrows, Li, and Geiss

Diabetes Care ◽  
2010 ◽  
Vol 33 (5) ◽  
pp. e69-e69 ◽  
Author(s):  
E. Villar ◽  
S. P. McDonald ◽  
C. Couchoud
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
The U.S

Clinical Outcomes and Mortality among Patients Hospitalized with Hypoglycemia and End-Stage Renal Disease in the U.S.

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 401-P
Author(s):  
RODOLFO J. GALINDO ◽  
CAROLINA R. HURTADO ◽  
FRANCISCO J. PASQUEL ◽  
PRIYATHAMA VELLANKI ◽  
GUILLERMO E. UMPIERREZ
Keyword(s):  
Renal Disease ◽  
Clinical Outcomes ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
The U.S

What can we learn from the U.S. expanded end-stage renal disease bundle?

Health Policy ◽  
2013 ◽  
Vol 110 (2-3) ◽  
pp. 164-171 ◽  
Author(s):  
James D. Chambers ◽  
Daniel E. Weiner ◽  
Sarah K. Bliss ◽  
Peter J. Neumann
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Stage Renal Disease ◽  
End Stage ◽  
The U.S

Policies Regarding Treatment of End-Stage Renal Disease in the United States and United Kingdom

1986 ◽  
Vol 2 (2) ◽  
pp. 253-274 ◽  
Author(s):  
Susan Klein Marine ◽  
Roberta G. Simmons
Keyword(s):  
United States ◽  
Kidney Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Well Being ◽  
The United States ◽  
The Body ◽  
Stage Renal Disease ◽  
End Stage ◽  
The U.S

The treatment of End-Stage Renal Disease (ESRD) represents a victory for medical technology. Dialysis and kidney transplantation, developed in the early 1960s, offer alternative treatments to patients whose own kidneys no longer function; before, these patients faced a terminal diagnosis. Dialysis is a mechanical treatment in which the patient is connected to a machine that cleanses the blood of impurities and returns it to the body. Although recent innovations (e.g., continuous ambulatory peritoneal dialysis—CAPD) facilitate patient independence from a machine, replacement of the diseased kidneys is the most desirable and least expensive treatment for many patients (33;39). Kidney transplantation remains the most effective and common type of transplantation, and a new kidney (from a living-related or cadaver donor) often dramatically improves the recipient's health and general well-being (20;39). Now, in the mid-1980s, these technologies are no longer new and innovative. Further analysis of these established but costly technologies provides a perspective on the long-range implications of innovations in patient care: while some new issues have emerged, many problems originally associated with these treatments seem to have intensified. Access to treatment remains a central issue, closely linked to the dilemma of equity versus cost. The contrast in the access provided by the United States and Great Britain is dramatic (40); in 1982, the rate of ESRD treatment within the U.S. was twice that of the U.K. (353 versus 160 patients per million) (37). The U.S. policy is basically one of unlimited access, whereas the U.K. has restricted access.

scholarly journals Level of renal function at the initiation of dialysis in the U.S. end-stage renal disease population

1999 ◽  
Vol 56 (6) ◽  
pp. 2227-2235 ◽  
Author(s):  
Gregorio T. Obrador ◽  
Pradeep Arora ◽  
Annamaria T. Kausz ◽  
Robin Ruthazer ◽  
Brian J.G. Pereira ◽  
...  
Keyword(s):  
Renal Function ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Initiation Of Dialysis ◽  
Stage Renal Disease ◽  
End Stage ◽  
The U.S
Sign in / Sign up

Export Citation Format

Share Document